|Slideshows|July 1, 2016

Psychiatry Roundup: Orlando, Physicians Unite, Defunct Study

In the aftermath of the Orlando massacre, nearly half a million physicians declared war on gun violence. This story and more in our psychiatry roundup.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Intimate Partner Violence and Psychiatric Leadership: Clinical Perspectives

ByJames Rachal, MD

May 16th 2026

Psyched Perspectives: Building Community in Psychiatric Practice, Reflections From Lindsay Hill, DNP, PMHNP

ByFrank A. Clark, MD,Lindsay Hill, DNP, PMHNP

May 1st 2026

Why Are Assisted Suicide and Euthanasia Not Accepted in Eastern Cultures?

ByRonald W. Pies, MD,Cynthia M.A. Geppert, MD, PhD, MA, MPH, MSBE, DPS, MSJ,Mark S. Komrad, MD, DFAPA

April 3rd 2026

Culture as Wind: Adapting Recovery and Shared Decision-Making Across Cultures

ByYasuhiro Kotera, PhD

March 25th 2026

Diagnostic Validators and the Question of What Really Exists

ByS. Nassir Ghaemi, MD, MPH,Mark L. Ruffalo, MSW, DPsa

March 23rd 2026

Latest CME

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Psychiatry Roundup: Orlando, Physicians Unite, Defunct Study

Related Content

Intimate Partner Violence and Psychiatric Leadership: Clinical Perspectives

Psyched Perspectives: Building Community in Psychiatric Practice, Reflections From Lindsay Hill, DNP, PMHNP

Why Are Assisted Suicide and Euthanasia Not Accepted in Eastern Cultures?

Culture as Wind: Adapting Recovery and Shared Decision-Making Across Cultures

Diagnostic Validators and the Question of What Really Exists

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Trending on Psychiatric Times

Remlifanserin for the Treatment of Alzheimer Disease Psychosis Receives FDA Fast Track Designation

Future DSM Plans Overlook Core Problem of Validity

Targeting APOE4: A Promising Therapeutic Strategy for Alzheimer Disease

Bipolar Disorder in Women of Childbearing Age: Proper Treatment Before Pregnancy

Assessing Antipsychotics as Antidepressant Adjuncts